{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:15:04Z","timestamp":1780488904248,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG BE4443\/14-1 FIBROMIR"],"award-info":[{"award-number":["DFG BE4443\/14-1 FIBROMIR"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-PRCI-18-CE92-0009-01"],"award-info":[{"award-number":["ANR-PRCI-18-CE92-0009-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.112930","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T22:53:52Z","timestamp":1649717632000},"page":"112930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A role for metformin in the treatment of Dupuytren disease?"],"prefix":"10.1016","volume":"150","author":[{"given":"Alberto","family":"Baeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Levraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Diazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Camuzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Cegarra-Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Ploumellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Fassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Rezzonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Bellusci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Vassaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2022.112930_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease","volume":"6","author":"Shih","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112930_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-0004.2005.00504.x","article-title":"Mapping of an autosomal dominant gene for Dupuytren\u2019s contracture to chromosome 16q in a Swedish family","volume":"68","author":"Hu","year":"2005","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.biopha.2022.112930_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhsa.2005.09.018","article-title":"The heritability of Dupuytren\u2019s disease: familial aggregation and its clinical significance","volume":"31","author":"Hindocha","year":"2006","journal-title":"J. Hand Surg. Am."},{"issue":"8","key":"10.1016\/j.biopha.2022.112930_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jclinepi.2003.11.015","article-title":"A prospective study linked both alcohol and tobacco to Dupuytren\u2019s disease","volume":"57","author":"Godtfredsen","year":"2004","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112930_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.otsr.2014.05.013","article-title":"Hospitalization for Dupuytren\u2019s disease: a French national descriptive analysis, 2002\u20132009","volume":"100","author":"Maravic","year":"2014","journal-title":"Orthop. Trauma. Surg. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbspin.2011.03.003","article-title":"Needle aponeurotomy in Dupuytren\u2019s disease","volume":"79","author":"Beaudreuil","year":"2012","journal-title":"Jt. Bone Spine"},{"issue":"10","key":"10.1016\/j.biopha.2022.112930_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.112930_bib8","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1097\/PRS.0b013e3181f83129","article-title":"An evidence-based approach to Dupuytren\u2019s contracture","volume":"126","author":"Brandt","year":"2010","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.biopha.2022.112930_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8794-5-15","article-title":"Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren\u2019s Contracture","volume":"5","author":"Satish","year":"2012","journal-title":"BMC Med. Genom."},{"issue":"4","key":"10.1016\/j.biopha.2022.112930_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1753193409103729","article-title":"Histological staging and Dupuytren\u2019s disease recurrence or extension after surgical treatment: a retrospective study of 124 patients","volume":"34","author":"Balaguer","year":"2009","journal-title":"J. Hand Surg. Eur. Vol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112930_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren\u2019s disease","volume":"365","author":"Dolmans","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib12","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/s41467-020-16264-y","article-title":"Cellular census of human fibrosis defines functionally distinct stromal cell types and states","volume":"11","author":"Layton","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jid.2021.05.030","article-title":"Deciphering mesenchymal drivers of human Dupuytren\u2019s disease at single-cell level","volume":"142","author":"Dobie","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112930_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-4-14","article-title":"Elevated transforming growth factor beta and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren\u2019s disease fibroblasts","volume":"4","author":"Krause","year":"2011","journal-title":"Fibrogenes. Tissue Repair"},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0363-5023(05)80067-X","article-title":"Transforming growth factor-beta: possible roles in Dupuytren\u2019s contracture","volume":"20","author":"Kloen","year":"1995","journal-title":"J. Hand Surg. Am."},{"issue":"5","key":"10.1016\/j.biopha.2022.112930_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/J.JHSB.2006.05.007","article-title":"Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren\u2019s fibroblasts","volume":"31","author":"Wong","year":"2006","journal-title":"J. Hand Surg. Br."},{"issue":"10","key":"10.1016\/j.biopha.2022.112930_bib18","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target","volume":"110","author":"Verjee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0194599813513880","article-title":"Metformin reduces TGF-beta1-induced extracellular matrix production in nasal polyp-derived fibroblasts","volume":"150","author":"Park","year":"2014","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12931-016-0420-x","article-title":"Metformin attenuates lung fibrosis development via NOX4 suppression","volume":"17","author":"Sato","year":"2016","journal-title":"Respir. Res."},{"issue":"8","key":"10.1016\/j.biopha.2022.112930_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.112930_bib22","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/s41467-019-10839-0","article-title":"Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis","volume":"10","author":"Kheirollahi","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2022.112930_bib23","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/TP.0000000000002864","article-title":"Metformin attenuates cyclosporine A-induced renal fibrosis in rats","volume":"103","author":"Lin","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2022.112930_bib24","doi-asserted-by":"crossref","first-page":"6673525","DOI":"10.1155\/2021\/6673525","article-title":"Metformin and fibrosis: a review of existing evidence and mechanisms","volume":"2021","author":"Wu","year":"2021","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2022.112930_bib25","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2022.112930_bib26","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2022.112930_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2015.01.042","article-title":"Activation of AMPK by metformin inhibits TGF-beta-induced collagen production in mouse renal fibroblasts","volume":"127","author":"Lu","year":"2015","journal-title":"Life Sci."},{"issue":"16","key":"10.1016\/j.biopha.2022.112930_bib28","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1158\/0008-5472.CAN-06-1209","article-title":"Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors","volume":"66","author":"Martinico","year":"2006","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.biopha.2022.112930_bib29","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1158\/1078-0432.CCR-08-0410","article-title":"Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors","volume":"14","author":"Peerlinck","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2022.112930_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008660","article-title":"Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomics","volume":"16","author":"Cambien","year":"2020","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.biopha.2022.112930_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1164\/rccm.201807-1237OC","article-title":"The long noncoding RNA DNM3OS is a reservoir of fibromirs with major functions in lung fibroblast response to TGF-beta and pulmonary fibrosis","volume":"200","author":"Savary","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2022.112930_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/bs.mcb.2014.10.008","article-title":"Measurement of cell traction forces with ImageJ","volume":"125","author":"Martiel","year":"2015","journal-title":"Methods Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112930_bib33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jhsa.2015.02.018","article-title":"Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials","volume":"40","author":"Badalamente","year":"2015","journal-title":"J. Hand Surg. Am."},{"issue":"10","key":"10.1016\/j.biopha.2022.112930_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhsa.2021.07.005","article-title":"Dupuytren contractures: an update of recent literature","volume":"46","author":"Boe","year":"2021","journal-title":"J. Hand Surg. Am."},{"issue":"12","key":"10.1016\/j.biopha.2022.112930_bib35","doi-asserted-by":"crossref","first-page":"eaay0370","DOI":"10.1126\/sciadv.aay0370","article-title":"Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis","volume":"5","author":"Izadi","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2022.112930_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ebiom.2018.06.022","article-title":"Anti-tumour necrosis factor therapy for Dupuytren\u2019s disease: a randomised dose response proof of concept phase 2a clinical trial","volume":"33","author":"Nanchahal","year":"2018","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.biopha.2022.112930_bib37","doi-asserted-by":"crossref","first-page":"C873","DOI":"10.1152\/ajpcell.00604.2020","article-title":"The intersection of metformin and inflammation","volume":"320","author":"Bharath","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.112930_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105971","article-title":"Exploring metformin as a candidate drug for rosacea through network pharmacology and experimental validation","volume":"174","author":"Li","year":"2021","journal-title":"Pharm. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:40:08Z","timestamp":1780486808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"alternative-id":["S0753332222003195"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112930","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role for metformin in the treatment of Dupuytren disease?","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112930"}}